CRISPR & Genetic Engineering: Rewriting the Code of Life

14 min readUpdated Jan 21, 2026Loading...
"We are now in the era of intentional human evolution. The question is not whether we will edit human genes, but how, when, and by whose hand." — George Church, Harvard geneticist

Overview

CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats) is a revolutionary gene-editing technology that allows precise modification of DNA sequences in living organisms. Discovered in bacterial immune systems and adapted as a tool by scientists Jennifer Doudna and Emmanuelle Charpentier (Nobel Prize, 2020), CRISPR has transformed genetic research and opened the door to editing the human genome itself.1

Within conspiracy frameworks, CRISPR represents the technological foundation for a new eugenics—the ability to engineer human beings according to specification, creating enhanced humans for those who can afford it while potentially mandating genetic modifications for the masses. When combined with the documented history of eugenics movements and the interests of wealthy elites in life extension and enhancement, CRISPR appears not as neutral technology but as the means for remaking humanity itself.2

------

Cost~$50$5,000-$10,000+
Time to designHoursWeeks to months
ComplexityRequires only guide RNAComplex protein engineering
PrecisionHighModerate
MultiplexingEasy (edit many genes at once)Very difficult

Newer Developments

CRISPR continues to evolve:5

Base Editing: Directly converts one DNA letter to another without cutting both strands. Higher precision, fewer unintended effects.

Prime Editing: "Search and replace" function allowing any small change without double-strand breaks. Most precise yet.

CRISPR Interference (CRISPRi): Turns genes off without cutting DNA.

CRISPR Activation (CRISPRa): Turns genes on without editing sequence.

Cas12 and Cas13: Alternative enzymes with different capabilities, including RNA editing.

Current Applications

Medical Treatment (Somatic Gene Therapy)

CRISPR is already treating human disease:6

Sickle Cell Disease and Beta-Thalassemia: In 2023, the FDA approved Casgevy (exagamglogene autotemcel), the first CRISPR-based therapy. Patient blood cells are edited outside the body and returned, potentially curing these painful, life-threatening conditions.

Cancer Immunotherapy: CAR-T cells edited with CRISPR to enhance cancer-fighting ability. Clinical trials show promising results.

HIV Treatment: CRISPR targeting HIV DNA integrated into patient genomes. Early trials exploring potential cure rather than just management.

Hereditary Blindness: Clinical trials editing retinal cells to restore vision in Leber congenital amaurosis patients.

Transthyretin Amyloidosis: CRISPR editing liver cells to stop production of harmful protein.

Agricultural Applications

CRISPR is transforming agriculture:7

  • Disease-resistant crops
  • Drought-tolerant plants
  • Increased nutritional content
  • Faster crop development
  • Non-browning mushrooms (first CRISPR food approved, 2016)
  • Hornless dairy cattle

Research Tools

CRISPR has accelerated basic research:8

  • Creating animal models of human disease
  • Functional genomics (systematically testing gene function)
  • Drug target discovery
  • Understanding cancer biology
  • Developmental biology research

Germline Editing: The Red Line

Somatic vs. Germline

Critical distinction in gene editing:9

Somatic Editing: Modifying cells in a living person. Changes affect only that individual and are not inherited.

Germline Editing: Modifying eggs, sperm, or early embryos. Changes pass to all future generations.

The scientific consensus, codified in international guidelines, has been that germline editing for reproduction should not be performed—a line that was crossed.

He Jiankui and the "CRISPR Babies"

In November 2018, Chinese scientist He Jiankui announced the birth of twin girls, Lulu and Nana, with CRISPR-edited genomes—the first genetically modified humans:10

What He Did:

  • Edited embryos to disable CCR5 gene, theoretically conferring HIV resistance
  • Implanted embryos resulting in twin birth
  • A third edited baby was born later

Scientific Problems:

  • HIV resistance could have been achieved through simpler means
  • CCR5 has other important functions (cognition, infection response)
  • The editing was incomplete (mosaicism)
  • Off-target effects were not fully characterized
  • Long-term consequences unknown

Regulatory Response:

  • He was sentenced to three years in Chinese prison
  • International scientific community condemned the experiment
  • WHO established expert advisory committee on human genome editing
  • Calls for moratorium on clinical germline editing

The Genie Out of the Bottle

Despite condemnation, He's experiment demonstrated:11

  • The technology works (babies were born)
  • Determined actors will proceed regardless of guidelines
  • Enforcement across borders is nearly impossible
  • Reproductive tourism for genetic enhancement is likely
  • The "unthinkable" has been thought—and done

The New Eugenics

Historical Eugenics

Understanding current debates requires historical context:12

American Eugenics (1900s-1970s):

  • 60,000+ forced sterilizations in the United States
  • "Fitter family" competitions at state fairs
  • Immigration restrictions based on racial "fitness"
  • Buck v. Bell Supreme Court case upholding sterilization
  • Direct influence on Nazi eugenics programs

Nazi Eugenics (1933-1945):

  • Compulsory sterilization of "unfit" individuals
  • T4 "euthanasia" program killing disabled persons
  • Culmination in Holocaust

Post-war Disavowal: After Nazi atrocities, eugenics became taboo. The word itself was abandoned even as practices continued under other names (population control, family planning in certain contexts).

"Liberal Eugenics"

Contemporary philosophers have developed frameworks for voluntary genetic enhancement:13

Key Arguments:

  • Reproductive autonomy includes genetic selection
  • Parents already shape children's development
  • Eliminating genetic disease is unambiguously good
  • Enhancement could be distinguished from treatment
  • Individual choice differs from state coercion

Critics Respond:

  • Individual choices aggregate into social patterns
  • Economic inequality creates unequal access
  • "Voluntary" is constrained by social pressure
  • Eliminates disabled people rather than disability
  • Opens door to new forms of discrimination

From Treatment to Enhancement

The treatment/enhancement distinction is philosophically unstable:14

What is "treatment"?What is "enhancement"?

Curing sickle cellAdding extra copies of hemoglobin genes
Restoring normal heightIncreasing height beyond normal
Treating depressionImproving mood beyond normal
Preventing genetic diseaseSelecting for intelligence genes

Where does treatment end and enhancement begin? Who decides what's "normal"? These questions become urgent as technology advances.

Designer Babies: Possibilities and Pathways

What Could Be Edited

Genetic influences on traits fall on a spectrum of feasibility:15

Already Possible (single genes):

  • Huntington's disease (elimination)
  • Sickle cell disease (correction)
  • Cystic fibrosis (correction)
  • CCR5/HIV resistance (He Jiankui)
  • Hereditary blindness variants

Near-Term Possible (emerging understanding):

  • Some forms of hereditary cancer risk
  • Certain metabolic disorders
  • Specific immune functions
  • Muscle development genes (myostatin)

Theoretically Possible (polygenic traits):

  • Height (thousands of genes, each small effect)
  • Intelligence (extremely complex genetics)
  • Personality traits (poorly understood genetics)
  • Physical appearance (partially understood)

The Polygenic Problem: Most traits people want to enhance—intelligence, athleticism, longevity—involve hundreds or thousands of genes, each with tiny effects and complex interactions. Editing one or even dozens of genes won't create super-geniuses.

Embryo Selection vs. Editing

A more immediate pathway involves selection, not editing:16

Preimplantation Genetic Testing (PGT):

  • IVF creates multiple embryos
  • Each embryo is genetically tested
  • "Best" embryo selected for implantation
  • No editing required

Polygenic Screening: Companies like Genomic Prediction now offer screening embryos for polygenic traits like intelligence, though scientific validity is contested.

Advantages: Uses existing, legal technology. No editing risks.

Limitations: Can only select among existing genetic variation. Requires IVF.

Social Stratification Implications

The Genetic Divide

Unequal access to genetic technology could create unprecedented stratification:17

Cost Barriers:

  • IVF costs $12,000-17,000 per cycle
  • PGT adds $3,000-6,000
  • Genetic enhancement would add more
  • Insurance unlikely to cover "enhancement"
  • Only wealthy can access

Cumulative Advantage:

  • Enhanced children perform better in school
  • Better educational outcomes lead to more resources
  • More resources enable enhancement of next generation
  • Genetic advantages compound over generations

New Discrimination: "Genoism" (genetic discrimination) could emerge:

  • Employment screening for genetic enhancement
  • Insurance based on genetic profile
  • Marriage/reproduction decisions based on genetic status
  • Social segregation by genetic tier

The "Gattaca" Scenario

The 1997 film Gattaca depicted a society divided by genetic engineering. Key elements now seem prescient:18

  • "Valid" (enhanced) vs. "Invalid" (natural) social classes
  • Genetic discrimination despite formal prohibition
  • Black market for genetic identity
  • Enhanced individuals monopolize opportunities
  • "Natural" humans become underclass

Elite Interest in Enhancement

Wealthy individuals and families have documented interest in genetic enhancement:19

  • Silicon Valley figures (Thiel, Altman, etc.) fund longevity and enhancement research
  • Epstein's reported interest in "seeding the human race" with his DNA
  • Billionaire-funded research into extreme life extension
  • Private genetic testing and enhancement services emerging

Regulatory Landscape

International Frameworks

Global regulation of germline editing is fragmented:20

Prohibited (legally binding):

  • Australia, Canada, France, Germany: Criminal penalties
  • Council of Europe Oviedo Convention (but many non-signatories)

Prohibited (guidelines):

  • China, Japan, UK, US: Not criminally banned but prohibited by research guidelines/funding restrictions

Permissive (regulated):

  • UK allows research on human embryos (not implantation)
  • Limited research permitted in many countries

Unregulated:

  • Many countries have no specific laws
  • Reproductive tourism to unregulated jurisdictions is possible

US Regulation

The United States has no law specifically prohibiting germline editing:21

  • FDA has authority over gene therapy but Congressional rider prohibits FDA reviewing germline editing applications
  • NIH guidelines prohibit federal funding for germline editing research
  • No federal law would prevent privately funded clinical germline editing
  • State laws vary

The Governance Gap

Current frameworks are inadequate:22

  • Technology advances faster than regulation
  • International coordination is weak
  • Enforcement across borders is nearly impossible
  • Wealthy individuals can access offshore services
  • "First mover" nations may gain advantage by permitting enhancement

Military and Enhancement Applications

Soldier Enhancement

Military interest in genetic enhancement is documented:23

DARPA Programs:

  • Research into enhanced endurance, strength, cognitive performance
  • Rapid healing and disease resistance
  • Environmental tolerance (altitude, temperature extremes)

Ethical Concerns:

  • Consent issues for military personnel
  • Coercion potential
  • Creating "super soldiers" arms race
  • Dehumanization of enemy

China: Reports of research into genetically enhanced soldiers, though specifics are unclear.

Athletic Enhancement

Sports represents a near-term battleground:24

  • Gene doping (introducing performance genes) already a concern
  • WADA bans gene editing for enhancement
  • Detection is extremely difficult
  • Underground gene therapy services emerging
  • Enhanced athletes could be undetectable

The Conspiracy Framework Interpretation

Transhumanist Agenda

Within the Pax Judaica framework, CRISPR enables:25

Elite Speciation: Creation of genetically superior ruling class, distinct from baseline humanity.

Controlled Evolution: Directing human evolution according to elite preferences rather than natural selection.

Ultimate Population Control: Genetic modification could include built-in controls—susceptibility to specific substances, reduced fertility, shortened lifespan for non-elites.

New Slavery: Genetically engineered servant class designed for obedience and specific functions.

Corporate Eugenics

The profit motive drives genetic engineering toward enhancement:26

  • Treatment markets are limited (only sick people)
  • Enhancement markets are unlimited (everyone could be "better")
  • Competition forces adoption ("if you don't enhance, your children will be disadvantaged")
  • Subscription models for ongoing genetic maintenance
  • Planned obsolescence in human genetics

Billionaire Breeding Programs

Conspiracy theorists point to documented elite interest:27

  • Jeffrey Epstein's stated interest in "seeding" the human race
  • Billionaire-funded sperm banks and reproductive technology
  • Silicon Valley transhumanist networks
  • Private genetic enhancement research

Religious Dimension

Some frameworks identify spiritual significance:28

  • "Playing God" as literal Luciferian rebellion
  • Corrupting God's creation (human genome)
  • Mark of the beast through genetic modification
  • Nephilim narrative (mixing of kinds)

Critical Analysis

What's Actually Possible

Separating capability from speculation:29

Now Possible:

  • Single-gene disease treatment
  • Embryo selection for single-gene traits
  • Basic somatic gene therapy

Near-Term (5-10 years):

  • Expanded disease treatment
  • Some enhancement in controlled settings
  • Better understanding of polygenic traits

Speculative/Long-Term:

  • Reliable intelligence enhancement
  • Complex trait engineering
  • "Designer babies" as commonly imagined
  • Genetic caste system

Scientific Limitations

Current constraints on genetic enhancement:30

Polygenic Complexity: Most desired traits involve thousands of genes with tiny effects. We can't reliably enhance them yet.

Off-Target Effects: CRISPR isn't perfectly precise. Unintended edits could cause cancer or other problems.

Epistasis: Genes interact in complex ways. Changing one may have unexpected effects through others.

Environment Still Matters: Even highly heritable traits are significantly influenced by environment. Genes aren't destiny.

Individual Variation: What's beneficial for one person might be harmful for another.

The "Genetic Determinism" Fallacy

Critics note overestimation of genetic influence:31

  • IQ is about 50% heritable—meaning 50% environmental
  • "Genius genes" have tiny individual effects
  • Gene-environment interactions are complex
  • Social factors remain more important than genetics for most outcomes

Ethical Frameworks

Disability Rights Perspective

Disabled advocates offer unique critique:32

  • Genetic elimination of disability eliminates disabled people, not suffering
  • "Curing" deafness devalues Deaf culture
  • Enhancement assumes single standard of "good" human
  • Disability is partly social, not just medical
  • Neurodiversity has value

Social Justice Concerns

Progressive critics focus on inequality:33

  • Unequal access compounds existing inequality
  • Historical eugenics targeted marginalized groups
  • Enhancement benefits those already privileged
  • Genetic determinism justifies existing hierarchies
  • Public goods should be prioritized over private enhancement

Transhumanist Response

Enhancement advocates respond:34

  • Genetic enhancement is reproductive liberty
  • Opposition is "genetic conservatism"
  • Enhancement could be publicly provided
  • Benefits would eventually reach all
  • Limiting enhancement perpetuates genetic inequality

Related Articles

Further Reading

  • Scientific: Doudna and Isaacson provide accessible science
  • Ethical: Buchanan et al. offer philosophical framework
  • Historical: Black documents eugenics history
  • Investigative: Kirksey details the CRISPR babies case

This article is part of an educational encyclopedia examining conspiracy theories alongside documented developments. CRISPR technology is real and advancing rapidly; the conspiracy framework interpretation represents one analytical lens that should be evaluated critically alongside mainstream scientific and ethical perspectives.

Discussion(0 comments)

Join the conversationSign in to share your perspectiveSign In
Loading comments...

Contribute to this Article

Help improve this article by suggesting edits, adding sources, or expanding content.

Submit via EmailSend your edits

References

1
Doudna, Jennifer and Sternberg, Samuel. A Crack in Creation. Houghton Mifflin Harcourt, 2017. Nobel laureate's account.
2
This represents conspiracy framework interpretation, not scientific consensus.
3
Jiang, Fuguo and Doudna, Jennifer. "CRISPR-Cas9 Structures and Mechanisms," Annual Review of Biophysics, 2017.
4
Davies, Kevin. Editing Humanity. Pegasus Books, 2020. Technical comparison.
5
Recent scientific literature on CRISPR variants and developments.
6
FDA approval documentation; clinical trial publications.
7
USDA approvals; agricultural biotechnology publications.
8
Research methodology literature in molecular biology.
9
Bioethics literature distinguishing somatic and germline editing.
10
Kirksey, Eben. The Mutant Project. St. Martin's Press, 2020. Detailed investigation of He Jiankui case.
11
International Summit proceedings and subsequent analysis.
12
Black, Edwin. War Against the Weak. Four Walls Eight Windows, 2003. Definitive history of American eugenics.
13
Buchanan, Allen et al. From Chance to Choice. Cambridge University Press, 2001. Philosophical framework.
14
Bioethics literature on treatment/enhancement distinction.
15
Current understanding from genomics literature.
16
Knoepfler, Paul. GMO Sapiens. World Scientific, 2015.
17
Harari, Yuval Noah. Homo Deus. Harper, 2017. Analyzes potential stratification.
18
Analysis of Gattaca (1997) and its prescience.
19
Documented funding and statements from tech elite.
20
Nuffield Council on Bioethics, "Genome Editing and Human Reproduction," 2018.
21
US regulatory framework analysis from bioethics and legal scholarship.
22
Academic analysis of governance gaps.
23
DARPA documentation; military ethics literature.
24
WADA policies; sports medicine literature.
25
This represents conspiracy framework interpretation.
26
Economic analysis of biotechnology markets.
27
Documented statements and funding patterns.
28
Religious and eschatological interpretations from various sources.
29
Scientific consensus from Nature, Science, and review articles.
30
Technical limitations from molecular biology literature.
31
Behavioral genetics literature on heritability.
32
Disability studies scholarship on genetic technology.
33
Social justice perspectives in bioethics literature.
34
Transhumanist philosophical literature (Stock, Green, etc.).